They say this sort of stuff
“I mean, like you say, we don’t know the exact figure — but I think the ballpark is probably about right. Whether it was 50,000 or 60,000 patients, there’s just not enough precise data. There’s also the possibility of some double-counting in the supply chain at times. But overall, I don’t think it’s far off that number.
Personally, I’d like to see us hit 100,000 patients — that would be a meaningful milestone, and it feels like it’s within reach. I don’t think things are slowing down at all. Sure, percentage growth may taper, but in terms of absolute numbers, new patients are coming in every month and the momentum feels strong. Word of mouth is improving too.
So yes, I think 100,000 is very achievable. At the top end, maybe 120,000 or even 150,000 could be possible. But beyond that, within the current timeframe, we’d probably need to see a significant regulatory shift.
There’s still going to be that gap between us and markets like Germany or Australia — people often compare them, but even though they’re also medical markets, they’re fundamentally quite different in structure and access. Closing that gap will take time.”
Read more at
